Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nobuyuki YamamotoMasahiro Fukuoka

Abstract

This phase III trial of concurrent thoracic radiotherapy (TRT) was conducted to compare third-generation chemotherapy with second-generation chemotherapy in patients with unresectable stage III non-small-cell lung cancer (NSCLC). Eligible patients received the following treatments: A (control), four cycles of mitomycin (8 mg/m(2) on day 1)/vindesine (3 mg/m(2) on days 1, 8)/cisplatin (80 mg/m(2) on day 1) plus TRT 60 Gy (treatment break for 1 week); B, weekly irinotecan (20 mg/m(2))/carboplatin (area under the plasma concentration-time curve [AUC] 2) for 6 weeks plus TRT 60 Gy, followed by two courses of irinotecan (50 mg/m(2) on days 1, 8)/carboplatin (AUC 5 on day 1); C, weekly paclitaxel (40 mg/m(2))/carboplatin (AUC 2) for 6 weeks plus TRT 60 Gy, followed by two courses of paclitaxel (200 mg/m(2) on day 1)/carboplatin (AUC 5 on day 1). The median survival time and 5-year survival rates were 20.5, 19.8, and 22.0 months and 17.5%, 17.8%, and 19.8% in arms A, B, and C, respectively. Although no significant differences in overall survival were apparent among the treatment arms, noninferiority of the experimental arms was not achieved. The incidences of grade 3 to 4 neutropenia, febrile neutropenia, and gastrointestinal disorder...Continue Reading

References

Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H ChoyT Kennedy
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K FuruseY Ariyoshi
Jun 7, 2000·Lancet·P C HoffmanE E Vokes
Nov 27, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J P van Meerbeeck
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chandra P BelaniWalter J Curran
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Everett E VokesUNKNOWN Cancer and Leukemia Group B

❮ Previous
Next ❯

Citations

Nov 26, 2010·Nature Reviews. Clinical Oncology·Allen M Chen, Primo N Lara
Aug 29, 2012·Nature Reviews. Clinical Oncology·Allan Price
Feb 27, 2013·Nature Reviews. Clinical Oncology·Tetsuya MitsudomiYasushi Yatabe
Sep 22, 2012·Interactive Cardiovascular and Thoracic Surgery·Volker StegerThorsten Walles
Dec 24, 2010·Current Opinion in Oncology·Paul BaasMichel van den Heuvel
May 31, 2014·Gynecologic Oncology·Sarah A MilgromKaled M Alektiar
Oct 31, 2014·General Thoracic and Cardiovascular Surgery·Masafumi Yamaguchi, Kenji Sugio
Jan 31, 2015·Cancer Investigation·Nam P NguyenUNKNOWN International Geriatric Radiotherapy Group
Jul 26, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kazuyuki TsujinoMasahiko Ando
Jun 29, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thomas E StinchcombeRamaswamy Govindan
Nov 5, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yukito IchinoseMasahiro Fukuoka
Jan 16, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Takaaki TokitoTomoaki Hoshino
May 31, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Akito HataYukihiro Imai
Sep 4, 2013·The Annals of Thoracic Surgery·Masafumi YamaguchiYukito Ichinose
May 7, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shunichi SugawaraUNKNOWN North Japan Lung Cancer Study Group
Jun 12, 2012·International Journal of Radiation Oncology, Biology, Physics·David A PalmaGeorge Rodrigues
Jan 13, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Melike OzcelikMahmut Gumus
Mar 16, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Luhua WangXiangru Zhang
Mar 15, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jun Sakakibara-KonishiMasaharu Nishimura
Dec 25, 2015·International Journal of Radiation Oncology, Biology, Physics·Hidehito HorinouchiYuichiro Ohe
Dec 30, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S E Schild, E E Vokes
Jun 11, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·Biniam KidaneKazuhiro Yasufuku

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A AupérinJean-Pierre Pignon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Yukito IchinoseMasahiro Fukuoka
© 2021 Meta ULC. All rights reserved